Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.47 +0.70%
EPS Growth %: -27.8%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -27.8%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Google launches Gemini 3.8 Flash and a cybersecurity model variant
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
